FDA Center for Drug Evaluation & Research Issues Warning Letter to Shoolin Pharma Chem
September 02, 2026
September 02, 2026
WASHINGTON, Sept. 2 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Shoolin Pharma Chem LLP from its Center for Drug Evaluation and Research:
* * *
Recipient: Dr. Santosh R. Patel and Mr. Rajendra C. Patel, Managing Directors, Shoolin Pharma Chem LLP, 412 Deam Rise, Nr. Hetarth Park Plot, Science City Road, Sola, Ahmedabad 380059 Gujarat, India, (b)(4)
Issuing Office: Center for Drug Ev . . .
* * *
Recipient: Dr. Santosh R. Patel and Mr. Rajendra C. Patel, Managing Directors, Shoolin Pharma Chem LLP, 412 Deam Rise, Nr. Hetarth Park Plot, Science City Road, Sola, Ahmedabad 380059 Gujarat, India, (b)(4)
Issuing Office: Center for Drug Ev . . .